For GPs
Designed to show whether important work is being finished.
Partners carry the responsibility for work they cannot personally see. Reedley is designed to make that work visible — the evidence behind every item, a named owner, and evidence of what actually happened — with every clinical decision left to a named person.
The demo opens the same synthetic clinic letter.
In practice
A clinician-controlled review, step by step.
One synthetic clinic letter with two kinds of content: a change for a prescriber, and conditional advice, which is flagged for a clinician to review and never treated as an instruction (shown here routed to a GP as a decision: Illustrative).
Cardiology outpatients · Northfield General Hospital (fictional)Clinic 30 Sep 2026 · received 4 Oct 2026 08:31 · Funmilayo ADEYEMI · NHS 999 000 0069 · identity matched
¶3 Plan: increase ramipril to 10 mg once daily and recheck renal function in 1–2 weeks.
¶4 Consider stopping amlodipine if ankle swelling persists.
Task lane: a change for a prescriberDecision lane: conditional wording, routed to a GP
01 Identified
4 Oct 2026 · 10:05 · Reedley
Task lane · ¶3 → K. AHMED, clinical pharmacist
Identified
¶3 “increase ramipril to 10 mg once daily and recheck renal function in 1–2 weeks” → a medication change for a prescriber.
Decision lane · ¶4 → Dr S. PATEL, GP
Identified · conditional wording
¶4 “Consider stopping amlodipine if ankle swelling persists.” → conditional wording. Never turned into a medication task.
02 Reviewed by a named clinician
4 Oct 2026 · K. AHMED, clinical pharmacist · Dr S. PATEL, GP
Task lane · ¶3 → K. AHMED, clinical pharmacist
Reviewed · K. AHMED
K. AHMED examines the cited passage beside the record (ramipril 5 mg one daily) and accepts the item.
Decision lane · ¶4 → Dr S. PATEL, GP
Reviewed · Dr S. PATEL
Dr S. PATEL sees ¶4 highlighted, with the record beside it. There is no Accept button on a decision: the GP decides, Reedley records that a decision was made.
Review-level floor. Each kind of work has a minimum review level that practice settings cannot lower, enforced in Reedley’s screens only (no authenticated user yet). draft, awaiting CSO sign-off
03 Assigned
4 Oct 2026 · K. AHMED, clinical pharmacist
Task lane · ¶3 → K. AHMED, clinical pharmacist
Assigned
Owner K. AHMED · prescriber decision required · due: set when the prescriber records the dose decision.
Decision lane · ¶4 → Dr S. PATEL, GP
Routed · awaiting GP decision
Routed to Dr S. PATEL, GP · awaiting GP decision. No owner can be changed to a non-clinician: the review-level floor for a clinical decision is a clinician (draft, awaiting CSO sign-off).
No Accept button. Reedley does not decide whether to stop a medicine.
Review-level floor. Each kind of work has a minimum review level that practice settings cannot lower, enforced in Reedley’s screens only (no authenticated user yet). draft, awaiting CSO sign-off
04 Actioned, then evidenced
4 Oct 2026 15:30 · 7 Oct 2026 16:00 · Dr S. PATEL, GP · Reedley, from the clinical record (Simulated)
Task lane · ¶3 → K. AHMED, clinical pharmacist
Verified 4 Oct 15:30 → Closed · completed
Ramipril 10 mg once daily recorded and issued 4 Oct 15:30 (Simulated). Record shows 10 mg from 4 Oct. Limit: issued is not taken.
Decision lane · ¶4 → Dr S. PATEL, GP
Decision recorded 7 Oct 16:00 → Closed · completed
A decision was recorded by Dr S. PATEL 7 Oct 16:00 (Simulated). Reedley does not show what was decided.
Oversight. Who decided, when, on what evidence: kept in an append-only history. Before 7 Oct 16:00 the lane read “Routed to a clinician · awaiting GP decision”.
No practice uses Reedley yet · Tested on synthetic data only · No EMIS Web or SystmOne integration claimed
Designed for you
Built around how the work is really done.
Human oversight by design
Every proposal needs a named person; review levels are designed with floors practice settings cannot lower (draft, awaiting CSO sign-off).
Clinical safety approach
A hazard log is maintained with the build; a Clinical Safety Officer will own it before any real-world use.
Explainability
Confidence is shown as a reason a clinician can check, never as a percentage.
Practice-level visibility
What needs attention, where monitoring gaps are, and whether work is being finished.
Proportionate urgency
Urgency comes from authoritative sources, so that “critical” still means something.
Accountability
Decisions belong to named people and are recorded with the evidence used.
Honest status
Where the relevant capabilities stand.
As at 14 November 2026. Nothing here is in use with real patients.
| Capability | Status | Before real use |
|---|---|---|
| Document review with citations | Built · synthetic data | Accuracy with a model in the loop not yet measured |
| My Day worklist and six-state lifecycle | Built · synthetic data | Development storage only; a production store is planned |
| Review policy floors | Needs clinical sign-off | Need Clinical Safety Officer sign-off |
| Patient Context and What Changed | Built · synthetic data | Core platform · intended launch scope · what a clinician needs before opening the record; no real-record evaluation |
| Ask Reedley | Built · synthetic data | Core platform · intended launch scope · record-grounded answers that say when the records are not enough; no clinical advice; accuracy not measured |
| Clinical risk management (DCB0129) | In progress | Engineering draft only; no Clinical Safety Officer appointed, so no safety case exists yet |
| Live clinical-system integration | Needs supplier approval | No integration exists or is claimed |
The platform pages use three public states for the same facts: “Built · synthetic data” and “Needs clinical sign-off” are in the development build (synthetic data; draft rules unsigned), “In development” is partly built, and every other status here is not built. An illustrative demonstration can show parts that are not built.
Where you would work in the workstation: My Day · Patient Context · Ask Reedley
Not sure where to start? Take the five-question assessment
Does Reedley make clinical decisions?
No. It organises evidence and proposes work. Every decision belongs to a named person in your practice.
What would we need to do before using it with patients?
Your own DCB0160 assessment and a DPIA, supported by Reedley’s clinical safety case report and documentation, plus the relevant supplier approvals. None of that exists yet; it is part of a governed pilot.
Is it NHS-approved?
No. Reedley is independent and is not approved, endorsed or certified by the NHS.
Pilot interest
Help shape Reedley before it is finished.
We are looking for a small number of GP practices and primary care networks to work with us: first on synthetic walkthroughs, then — only with the right approvals, safeguards and agreements — on carefully governed evaluation.
- 01Register interestA short form. We reply personally to arrange a conversation. No commitment. Or request a demonstration
- 02Synthetic walkthroughYour team uses Reedley on synthetic patients and tells us what is wrong with it.
- 03Structured feedbackTimed tasks and short interviews, reported honestly, including what did not work.
- 04Governed evaluationOnly with a CSO-approved safety case (DCB0129), the practice’s DCB0160, an MHRA device determination, DSPT, a DPIA, a data processing agreement and supplier approvals in place.